Literature DB >> 26383680

Salvage Stereotactic Body Radiotherapy (SBRT) Following In-Field Failure of Initial SBRT for Spinal Metastases.

Isabelle Thibault1, Mikki Campbell1, Chia-Lin Tseng2, Eshetu G Atenafu3, Daniel Letourneau4, Eugene Yu5, B C John Cho4, Young K Lee1, Michael G Fehlings5, Arjun Sahgal6.   

Abstract

PURPOSE: We report our experience in salvaging spinal metastases initially irradiated with stereotactic body radiation therapy (SBRT), who subsequently progressed with imaging-confirmed local tumor progression, and were re-irradiated with a salvage second SBRT course to the same level. METHODS AND MATERIALS: From a prospective database, 56 metastatic spinal segments in 40 patients were identified as having been irradiated with a salvage second SBRT course to the same level. In addition, 24 of 56 (42.9%) segments had initially been irradiated with conventional external beam radiation therapy before the first course of SBRT. Local control (LC) was defined as no progression on magnetic resonance imaging at the treated segment, and calculated according to the competing risk model. Overall survival (OS) was evaluated for each patient treated by use of the Kaplan-Meier method.
RESULTS: The median salvage second SBRT total dose and number of fractions was 30 Gy in 4 fractions (range, 20-35 Gy in 2-5 fractions), and for the first course of SBRT was 24 Gy in 2 fractions (range, 20-35 Gy in 1-5 fractions). The median follow-up time after salvage second SBRT was 6.8 months (range, 0.9-39 months), the median OS was 10.0 months, and the 1-year OS rate was 48%. A longer time interval between the first and second SBRT courses predicted for better OS (P=.02). The crude LC was 77% (43/56), the 1-year LC rate was 81%, and the median time to local failure was 3.0 months (range, 2.7-16.7 months). Of the 13 local failures, 85% (11/13) and 46% (6/13) showed progression within the epidural space and paraspinal soft tissues, respectively. Absence of baseline paraspinal disease predicted for better LC (P<.01). No radiation-induced vertebral compression fractures or cases of myelopathy were observed.
CONCLUSION: A second course of spine SBRT, most often with 30 Gy in 4 fractions, for spinal metastases that failed initial SBRT is a feasible and efficacious salvage treatment option.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26383680     DOI: 10.1016/j.ijrobp.2015.03.029

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  26 in total

1.  Local control and patterns of failure for "Radioresistant" spinal metastases following stereotactic body radiotherapy compared to a "Radiosensitive" reference.

Authors:  K Liang Zeng; Arjun Sahgal; Zain A Husain; Sten Myrehaug; Chia-Lin Tseng; Jay Detsky; Arman Sarfehnia; Mark Ruschin; Mikki Campbell; Monica Foster; Sunit Das; Nir Lipsman; Georg A Bjarnason; Eshetu G Atenafu; Pejman Jabehdar Maralani; Hany Soliman
Journal:  J Neurooncol       Date:  2021-01-16       Impact factor: 4.130

2.  A comparison of stereotactic body radiation therapy for metastases to the sacral spine and treatment of the thoracolumbar spine.

Authors:  Roman O Kowalchuk; Michael R Waters; K Martin Richardson; Kelly Spencer; James M Larner; Jason P Sheehan; William H McAllister; Charles R Kersh
Journal:  J Radiosurg SBRT       Date:  2020

3.  Repeat reirradiation of the spinal cord: multi-national expert treatment recommendations.

Authors:  Carsten Nieder; Laurie E Gaspar; Dirk De Ruysscher; Matthias Guckenberger; Minesh P Mehta; Chad G Rusthoven; Arjun Sahgal; Eleni Gkika
Journal:  Strahlenther Onkol       Date:  2018-01-23       Impact factor: 3.621

4.  Intensity-modulated radiation therapy administered to a previously irradiated spine is effective and well-tolerated.

Authors:  H Doi; K Tamari; N Masai; Y Akino; D Tatsumi; H Shiomi; R-J Oh
Journal:  Clin Transl Oncol       Date:  2020-06-05       Impact factor: 3.405

Review 5.  Cumulative dose, toxicity, and outcomes of spinal metastases re-irradiation : Systematic review on behalf of the Re-Irradiation Working Group of the Italian Association of Radiotherapy and Clinical Oncology (AIRO).

Authors:  Antonio Pontoriero; Sara Lillo; Luciana Caravatta; Fabiana Bellafiore; Silvia Longo; Elisabetta Lattanzi; Silvana Parisi; Francesco Fiorica; Mariangela Massaccesi
Journal:  Strahlenther Onkol       Date:  2021-02-26       Impact factor: 3.621

Review 6.  Stereotactic body radiotherapy for spinal metastases: a review.

Authors:  Lanlan Guo; Lixin Ke; Ziyi Zeng; Chuanping Yuan; Ziwei Wu; Lei Chen; Lixia Lu
Journal:  Med Oncol       Date:  2022-05-23       Impact factor: 3.064

7.  Purposeful irradiation of the epidural space to enhance local control without compromising cord sparing in spine radiosurgery.

Authors:  P James Jensen; Jordan A Torok; C Rory Goodwin; Scott R Floyd; Qiuwen Wu; Q Jackie Wu; John P Kirkpatrick
Journal:  J Radiosurg SBRT       Date:  2022

Review 8.  Stereotactic body radiation therapy for lung, spine and oligometastatic disease: current evidence and future directions.

Authors:  Emma Maria Dunne; Ian Mark Fraser; Mitchell Liu
Journal:  Ann Transl Med       Date:  2018-07

Review 9.  Stereotactic Body Radiotherapy for Spinal Metastases: What are the Risks and How Do We Minimize Them?

Authors:  Joe H Chang; John H Shin; Yoshiya J Yamada; Addisu Mesfin; Michael G Fehlings; Laurence D Rhines; Arjun Sahgal
Journal:  Spine (Phila Pa 1976)       Date:  2016-10-15       Impact factor: 3.241

10.  Image-Guided Robotic Radiosurgery for the Treatment of Same Site Spinal Metastasis Recurrences.

Authors:  Felix Ehret; Lucas Mose; Markus Kufeld; Christoph Fürweger; Paul Windisch; Alfred Haidenberger; Christian Schichor; Jörg-Christian Tonn; Alexander Muacevic
Journal:  Front Oncol       Date:  2021-05-28       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.